Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2022 | Challenges in the diagnosis & management of Bing-Neel syndrome

Jahanzaib Khwaja • 10 Jun 2022
EHA 2022
Bing-Neel Syndrome Rare Diseases

Jahanzaib Khwaja, MD, FRCPath, University College London Hospitals NHS Foundation Trust, London, UK, highlights some of the challenges related to the diagnosis and management of Bing-Neel syndrome (BNS), emphasizing the importance of increasing awareness about BNS and defining clear guidelines about the management of this condition. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

More from Jahanzaib Khwaja

1:50
Insights into the management of Bing-Neel syndrome
Jahanzaib Khwaja • 10 Jun 2022
1:00
Unmet needs in AL amyloidosis: treatment options for R/R patients
Jahanzaib Khwaja • 10 Jun 2022
0:48
Belantamab mafodotin in relapsed systemic AL amyloidosis
Jahanzaib Khwaja • 10 Jun 2022

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:11
Personalized risk assessment for transplantation in primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
1:18
Autologous gene editing using the CRISPR system to treat primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
0:58
Hematological manifestations associated with primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals